Skip to main content

Table 2 Sexual and reproductive history of women screened for cervical cancer and proportion of VIA positivity, Addis Ababa, Ethiopia

From: Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia

Variable, n = 844 n(%) Name of health center
   AH W1H SH FMH LH
Menstrual History, p = 0.011
 Regularly 382 (45.3) 74 (49.3) 77 (45.3) 92 (47.2) 57 (43.8) 82 (41.2)
 Irregular 290 (34.4) 49 (32.7) 64 (37.6) 63 (32.3) 55 (42.3) 59 (29.6)
 Post coital spotting 7 (0.8) 0 (0) 4 (2.4) 1 (0.5) 1 (0.8) 1 (0.5)
 Menopause 165 (19.5) 27 (18.0) 25 (14.7) 39 (20.0) 17 (13.1) 57 (28.6)
Pregnancy status, p = 0.896
 Pregnant 1 (0.1) 0 (0) 0 (0) 1 (0.5) 0 (0) 0 (0)
 Non-pregnant 843 (99.9) 150 (100) 170 (100) 194 (99.5) 130 (100) 199 (100)
Parity, p = 0.004
 No 119 (14.1) 31 (20.7) 28 (16.5) 25 (12.8) 6 (4.6) 29 (14.6)
 1–3 575 (68.1) 89 (59.3) 99 (58.2) 136 (69.7) 115 (88.5) 136 (68.3)
 4–5 107 (12.7) 24 (16.0) 32 (18.8) 21 (10.8) 4 (3.1) 26 (13.1)
  > 5 43 (5.1) 6 (4.0) 11 (6.5) 13 (6.7) 5 (3.8) 8 (4.0)
Ever use of contraceptive methods, p = 0.009
 No 561 (66.5) 107 (71.3) 117 (68.8) 129 (66.2) 69 (53.1) 139 (69.8)
 Yes 283 (33.5) 43 (28.7) 53 (31.2) 66 (33.8) 61 (46.9) 60 (30.2)
Type of contraceptive method, p = 0.317
 Injectable 86 (30.4) 12 (27.9) 14 (26.9) 22 (33.3) 20 (33.3) 18 (30.0)
 OCP 42 (14.8) 10 (23.4) 8 (15.4) 11 (16.7) 5 (8.4) 6 (10.0)
 IUCD 45 (15.9) 8 (18.6) 10 (19.2) 11 (16.7) 3 (5.0) 13 (21.7)
 Implant 102 (36.0) 11 (25.6) 19 (36.5) 19 (28.8) 30 (50.0) 23 (38.3)
 Tubaligation 1 (0.4) 0 (0) 0 (0) 1 (1.5) 0 (0) 0 (0)
 Condom 7 (2.5) 2 (4.5) 1 (1.9) 2 (3.0) 2 (3.3) 0 (0)
Other corticosteroid use history, p = 0.556
 Yes 2 (0.2) 1 (0.7) 0 (0) 0 (0) 1 (0.8) 0 (0)
 No 842 (99.8) 149 (99.3) 170 (100) 195 (100) 129 (99.2) 199 (100)
Family hx of cervical cancer, p = 0.687
 Yes 5 (0.6) 2 (1.3) 1 (0.6) 1 (0.5) 0 (0) 1 (0.5)
 No 839 (99.4) 148 (98.7) 169 (99.4) 194 (99.5) 130 (100) 198 (99.5)
HIV status, p < 0.0001
 HIV positive 252 (29.9) 64 (42.7) 56 (32.9) 35 (26.9) 53 (27.2) 46 (23.1)
 HIV negative 447 (53.0) 47 (31.3) 81 (47.6) 48 (36.9) 124 (63.6) 146 (73.4)
 Unknown 145 (17.1) 39 (26) 33 (19.4) 47 (36.2) 18 (9.2) 7 (3.5)
STI history
 Yes 247 (29.3) 16 (10.7) 44 (25.9) 55 (28.2) 65 (50.0) 67 (33.7)
 No 597 (70.7) 134 (89.3) 126 (74.1) 140 (71.8) 65 (50.0) 132 (66.3)
VIA test result, p < 0.0001
 Positive 87 (10.3) 8 (5.3)) 8 (4.7) 30 (25.4) 11 (8.5)) 30 (25.1)
 Negative 757 (89.7) 142 (94.7 162 (95.3) 165 (84.6) 119 (91.5 169 (84.9)
  1. p-value is as per chi-square test done between sexual and reproductive characteristics; and health center type, AH Arada health center, W1H Woreda 1 health center, SH Selam health center, FH Felegemelese health center, LH Lideta health center, OCP Oral contraceptives, IUCD Intrauterine contraceptive device.